Beck Bode, LLC Merck & Co., Inc. Transaction History

Beck Bode, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$108.61 - $118.38 $191,044 - $208,230	1,759 New	1,759 $202,000
Q4 2022 Feb 07, 2023	BUY	$87.44 - $112.11 $1.6 Million - $2.05 Million	18,308 New	18,308 $2.03 Million
Q3 2021 Oct 22, 2021	SELL	$71.68 - $78.83 $114,831 - $126,285	-1,602 Closed	0 $0
Q2 2021 Jul 29, 2021	BUY	$70.31 - $77.77 $112,636 - $124,587	1,602 New	1,602 $125,000
Q1 2021 May 10, 2021	SELL	$68.86 - $81.11 $110,451 - $130,100	-1,604 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$73.18 - $82.95 $117,380 - $133,051	1,604 New	1,604 $133,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Beck Bode, LLC, based on Form 13F filings with the SEC.

Stay updated on Beck Bode, LLC with notifications on news.